Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.

@article{Boyer2017FibrinassociatedEL,
  title={Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.},
  author={Daniel F. Boyer and Penelope A. McKelvie and Laurence de Leval and Kerstin L. Edlefsen and Young-hyeh Ko and Zachary A Aberman and Alexandra E. Kovach and Aneal Masih and Ha Thanh Nishino and Lawrence M. Weiss and Alan K Meeker and Valentina Nardi and Maryknoll Mawanay Palisoc and Lina Shao and Stefania Pittaluga and Judith Ann Ferry and Nancy Lee Harris and Aliyah R. Sohani},
  journal={The American journal of surgical pathology},
  year={2017},
  volume={41 3},
  pages={299-312}
}
Incidental cases of localized fibrin-associated Epstein-Barr virus (EBV)+ large B-cell proliferations have been described at unusual anatomic sites and have been included in the category of diffuse large B-cell lymphoma associated with chronic inflammation (DLBCL-CI) in the WHO Classification. We describe 12 cases and review the literature to define their… CONTINUE READING